Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Capital Expenditures: 2011-2024

Historic Capital Expenditures for Agios Pharmaceuticals (AGIO) over the last 14 years, with Dec 2024 value amounting to $1.7 million.

  • Agios Pharmaceuticals' Capital Expenditures rose 271.12% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 337.29%. This contributed to the annual value of $1.7 million for FY2024, which is 68.67% up from last year.
  • According to the latest figures from FY2024, Agios Pharmaceuticals' Capital Expenditures is $1.7 million, which was up 68.67% from $999,000 recorded in FY2023.
  • Agios Pharmaceuticals' 5-year Capital Expenditures high stood at $14.1 million for FY2020, and its period low was $999,000 during FY2023.
  • Moreover, its 3-year median value for Capital Expenditures was $1.7 million (2024), whereas its average is $2.5 million.
  • Per our database at Business Quant, Agios Pharmaceuticals' Capital Expenditures crashed by 79.53% in 2023 and then soared by 68.67% in 2024.
  • Agios Pharmaceuticals' Capital Expenditures (Yearly) stood at $14.1 million in 2020, then crashed by 59.30% to $5.7 million in 2021, then declined by 14.98% to $4.9 million in 2022, then tumbled by 79.53% to $999,000 in 2023, then soared by 68.67% to $1.7 million in 2024.